Our study provides the first functional evidence that EphA2 may play critical roles in malignant cellular behavior such as resistance to apoptosis and, in part, invasion in RCC cells and that EphA2 appears to be functional particularly in non-metastatic RCC cells. The gene discussed is EPHA2; the disease is renal cell carcinoma.